These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14976534)

  • 1. Immunohistochemical expression of cytokeratins 7 and 20 in malignant salivary gland tumors.
    Nikitakis NG; Tosios KI; Papanikolaou VS; Rivera H; Papanicolaou SI; Ioffe OB
    Mod Pathol; 2004 Apr; 17(4):407-15. PubMed ID: 14976534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cytokeratin expression in the different cell types of salivary gland mucoepidermoid carcinoma.
    Azevedo RS; de Almeida OP; Kowalski LP; Pires FR
    Head Neck Pathol; 2008 Dec; 2(4):257-64. PubMed ID: 20614291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique expression of MUC3, MUC5AC and cytokeratins in salivary gland carcinomas.
    Lee JH; Lee JH; Kim A; Kim I; Chae YS
    Pathol Int; 2005 Jul; 55(7):386-90. PubMed ID: 15982212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CK7+/CK20- immunoexpression profile is typical of salivary gland neoplasia.
    Meer S; Altini M
    Histopathology; 2007 Jul; 51(1):26-32. PubMed ID: 17593078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
    Prasad AR; Savera AT; Gown AM; Zarbo RJ
    Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cribriform features of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma: cytokeratin and integrin expression.
    Araújo VC; Loducca SV; Sousa SO; Williams DM; Araújo NS
    Ann Diagn Pathol; 2001 Dec; 5(6):330-4. PubMed ID: 11745070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract.
    Franchi A; Massi D; Palomba A; Biancalani M; Santucci M
    Virchows Arch; 2004 Jul; 445(1):63-7. PubMed ID: 15175880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA3 immunohistochemical expression in salivary gland neoplasms.
    Schwartz LE; Begum S; Westra WH; Bishop JA
    Head Neck Pathol; 2013 Dec; 7(4):311-5. PubMed ID: 23604756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
    Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
    Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
    Chu P; Wu E; Weiss LM
    Mod Pathol; 2000 Sep; 13(9):962-72. PubMed ID: 11007036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
    Ozolek JA; Bastacky SI; Myers EN; Hunt JL
    Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.
    Rotellini M; Palomba A; Baroni G; Franchi A
    Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
    Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
    Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers.
    Reyes C; Jorda M; Gomez-Fernández C
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):283-6. PubMed ID: 22935826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cytokeratin 20 in mucinous bronchioloalveolar carcinoma.
    Shah RN; Badve S; Papreddy K; Schindler S; Laskin WB; Yeldandi AV
    Hum Pathol; 2002 Sep; 33(9):915-20. PubMed ID: 12378517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of distribution of cytokeratins 20 and 7 in special types of invasive breast carcinoma: a study of 123 cases.
    Tot T
    Ann Diagn Pathol; 1999 Dec; 3(6):350-6. PubMed ID: 10594286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites.
    Chan JK; Suster S; Wenig BM; Tsang WY; Chan JB; Lau AL
    Am J Surg Pathol; 1997 Feb; 21(2):226-34. PubMed ID: 9042291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRPS1 immunohistochemical expression in salivary gland tumors: A pilot study.
    Tjendra Y; Kerr DA; Gomez-Fernandez C; Velez Torres JM
    Am J Clin Pathol; 2023 Dec; 160(6):633-639. PubMed ID: 37565763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
    Foschini MP; Krausz T
    Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.